Nancy Wysenski is Director at CYTOKINETICS INC (CYTK). They have made 2 open-market trades across 1 company since 2011, most recently 2026-07-15.
CIK 0001294596
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $406K since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALKS | SELL · 10b5-1 | 2023-05-09 | 2023-05-10 | $31.24 | $1.3M | -3.5% | -0.7% | -10.1% |
| ALKS | BUY | 2020-02-24 | 2020-02-25 | $19.65 | $136K | -6.4% | -29.0% | -20.3% |
| ALKS | BUY | 2019-02-21 | 2019-03-18 | $33.09 | $270K | +1.9% | -5.2% | -36.6% |
| VRTX | SELL · 10b5-1 | 2012-05-14 | 2012-06-01 | $64.27 | $11.6M | -21.7% | -0.1% | -0.1% |
| VRTX | SELL · 10b5-1 | 2012-05-07 | 2012-05-09 | $56.06 | $10.4M | -21.7% | -0.1% | -0.1% |
| VRTX | SELL · 10b5-1 | 2012-01-19 | 2012-01-23 | $37.00 | $224K | -21.7% | -0.1% | -0.1% |
| VRTX | SELL · 10b5-1 | 2011-12-12 | 2011-12-13 | $28.90 | $145K | -21.7% | -0.1% | -0.1% |
| VRTX | SELL · 10b5-1 | 2011-11-15 | 2011-11-16 | $29.77 | $18K | -21.7% | -0.1% | -0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.